Too Good to Be True: Reflections on a Down Syndrome Clinical Trial
Ph.D. candidate Anna Moyer reflects on the bittersweet outcome of a clinical trial in children with Down syndrome.
Perspectives in Research
Satisfaction or stomachache? The science of digesting dairy
Ph.D. candidate Emma Spikol explores the science of digesting dairy.
Different rules for the vaccinated? It’s a slippery slope.
Like most front-line health care workers, resident Mark Lieber is now fully vaccinated against COVID-19. He discusses why he’s still wearing a mask.
Harder, Better, Faster, Stronger
Women in STEM are at a disadvantage at every stage of the academic pipeline and in almost every facet of their careers. Graduate student Veronica Busa reflects on how these statistics motivate her to focus her efforts.
Distributing Vaccines: Smallpox and the History of Vaccine Campaigns
The COVID-19 vaccine campaign will last for months, if not longer — it took over a hundred years for vaccination to wipe out smallpox. By examining how smallpox vaccination succeeded and failed, we can learn what may happen with the COVID-19 vaccine rollout and how to address potential pitfalls.
Citation Bias? In My Publication? Here’s How to Check
Although the makeup of academia and journal authors is becoming more diverse, the under-citation of women and authors of color is worsening. Here are some tools to check your manuscript.
The P-value of People
The prospect of helping patients is what attracted neuroscience graduate student Riley Bannon to the field of research, but this semester brought many humbling reminders that it is all too easy to lose sight of the bigger, human picture in translational research.
A New and Improved Poster Design
A new poster format that debuted last year claims to improve communication efficacy at scientific conferences. Stephanie Yang weighs in on her experiences with the format.
To Regrow Neurons, Fish Retinas Go Back in Time
Have you ever wondered why worms and fish can regenerate lost limbs while humans can’t? Read how Seth Blackshaw’s developmental neuroscience lab uses insights from zebrafish to regrow damaged eye neurons in mice.
Foghorn Therapeutics Breaks New Ground in Cancer Epigenetics
Epigenetic drugs are an emerging class of cancer therapeutics. In this article, Ph.D. candidate Roshan Chikarmane introduces Foghorn Therapeutics, its co-founder, Cigall Kadoch, and the science behind their drug development program.